Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021

May 13, 2021 8:00am EDT

Beyond Air® Appoints Peter Senior as Director of Business Development

May 03, 2021 8:00am EDT

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021

Apr 14, 2021 8:00am EDT

Beyond Air® to Present Abstracts at the American Thoracic Society Virtual Sessions in May 2021

Mar 24, 2021 8:00am EDT

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in March 2021

Mar 01, 2021 8:00am EST

Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease

Feb 16, 2021 8:00am EST

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update

Feb 09, 2021 4:05pm EST

Beyond Air® Schedules Third Fiscal Quarter 2021 Financial Results Conference Call and Webcast

Jan 15, 2021 4:10pm EST

Beyond Air® Initiates Patient Screening for LungFit™ GO Pilot Study for At-Home, Self-Administration of Inhaled Nitric Oxide in Nontuberculous Mycobacteria Lung Disease

Dec 07, 2020 8:00am EST

Beyond Air® to Participate in the 32nd Annual Piper Sandler Healthcare Conference from December 1-3, 2020

Nov 19, 2020 8:00am EST